185 related articles for article (PubMed ID: 12411474)
1. Interaction of sildenafil with cAMP-mediated vasodilation in vivo.
Schalcher C; Schad K; Brunner-La Rocca HP; Schindler R; Oechslin E; Scharf C; Suetsch G; Bertel O; Kiowski W
Hypertension; 2002 Nov; 40(5):763-7. PubMed ID: 12411474
[TBL] [Abstract][Full Text] [Related]
2. PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers.
Kimura M; Higashi Y; Hara K; Noma K; Sasaki S; Nakagawa K; Goto C; Oshima T; Yoshizumi M; Chayama K
Hypertension; 2003 May; 41(5):1106-10. PubMed ID: 12695418
[TBL] [Abstract][Full Text] [Related]
3. The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men.
Dishy V; Sofowora G; Harris PA; Kandcer M; Zhan F; Wood AJ; Stein CM
Clin Pharmacol Ther; 2001 Sep; 70(3):270-9. PubMed ID: 11557915
[TBL] [Abstract][Full Text] [Related]
4. Does sildenafil indirectly inhibit phosphodiesterase 3 in vascular smooth muscle?
Maurice DH
Hypertension; 2003 Mar; 41(3):e2. PubMed ID: 12623968
[No Abstract] [Full Text] [Related]
5. Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.
Attinà TM; Malatino LS; Maxwell SR; Padfield PL; Webb DJ
J Hypertens; 2008 Mar; 26(3):501-7. PubMed ID: 18300861
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
Webb DJ; Freestone S; Allen MJ; Muirhead GJ
Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
[TBL] [Abstract][Full Text] [Related]
7. Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue.
Stief CG; Uckert S; Becker AJ; Harringer W; Truss MC; Forssmann WG; Jonas U
Urology; 2000 Jan; 55(1):146-50. PubMed ID: 10654914
[TBL] [Abstract][Full Text] [Related]
8. Effects of sildenafil on retinal blood flow and flicker-induced retinal vasodilatation in healthy subjects.
Polak K; Wimpissinger B; Berisha F; Georgopoulos M; Schmetterer L
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4872-6. PubMed ID: 14578411
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil increases sympathetically mediated vascular tone in humans.
Dopp JM; Agapitov AV; Sinkey CA; Haynes WG; Phillips BG
Am J Hypertens; 2013 Jun; 26(6):762-9. PubMed ID: 23443723
[TBL] [Abstract][Full Text] [Related]
10. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia.
Halcox JP; Nour KR; Zalos G; Mincemoyer RA; Waclawiw M; Rivera CE; Willie G; Ellahham S; Quyyumi AA
J Am Coll Cardiol; 2002 Oct; 40(7):1232-40. PubMed ID: 12383570
[TBL] [Abstract][Full Text] [Related]
11. Effects of sildenafil citrate on human hemodynamics.
Jackson G; Benjamin N; Jackson N; Allen MJ
Am J Cardiol; 1999 Mar; 83(5A):13C-20C. PubMed ID: 10078538
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta.
Mochida H; Inoue H; Takagi M; Noto T; Yano K; Kikkawa K
Eur J Pharmacol; 2002 Apr; 440(1):45-52. PubMed ID: 11959087
[TBL] [Abstract][Full Text] [Related]
13. Effects of sildenafil (viagra) on human myocardial contractility, in vitro arrhythmias, and tension of internal mammaria arteries and saphenous veins.
Cremers B; Scheler M; Maack C; Wendler O; Schäfers HJ; Südkamp M; Böhm M
J Cardiovasc Pharmacol; 2003 May; 41(5):734-43. PubMed ID: 12717104
[TBL] [Abstract][Full Text] [Related]
14. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro.
Jeremy JY; Ballard SA; Naylor AM; Miller MA; Angelini GD
Br J Urol; 1997 Jun; 79(6):958-63. PubMed ID: 9202566
[TBL] [Abstract][Full Text] [Related]
15. Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
Trachte AL; Lobato EB; Urdaneta F; Hess PJ; Klodell CT; Martin TD; Staples ED; Beaver TM
Ann Thorac Surg; 2005 Jan; 79(1):194-7; discussion 194-7. PubMed ID: 15620942
[TBL] [Abstract][Full Text] [Related]
16. Effects and mechanisms of action of sildenafil citrate in human chorionic arteries.
Maharaj CH; O'Toole D; Lynch T; Carney J; Jarman J; Higgins BD; Morrison JJ; Laffey JG
Reprod Biol Endocrinol; 2009 Apr; 7():34. PubMed ID: 19389232
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.
Weimann J; Ullrich R; Hromi J; Fujino Y; Clark MW; Bloch KD; Zapol WM
Anesthesiology; 2000 Jun; 92(6):1702-12. PubMed ID: 10839922
[TBL] [Abstract][Full Text] [Related]
18. Effect of sildenafil on coronary active and reactive hyperemia.
Chen Y; Du R; Traverse JH; Bache RJ
Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2319-25. PubMed ID: 11045968
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil citrate (Viagra) enhances vasodilatation by atrial natriuretic peptide in normal dogs.
Ishikura F; Beppu S; Asanuma T; Seward JB; Khandheria BK
Circ J; 2007 Dec; 71(12):1965-9. PubMed ID: 18037755
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via the cAMP/cGMP signaling pathway.
Andric SA; Janjic MM; Stojkov NJ; Kostic TS
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E544-50. PubMed ID: 20663985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
